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Abstract
Background: Evaluations of complex interventions in public health are frequently undermined by problems that
can be identified before the effectiveness study stage. Exploratory studies, often termed pilot and feasibility studies,
are a key step in assessing the feasibility and value of progressing to an effectiveness study. Such studies can
provide vital information to support more robust evaluations, thereby reducing costs and minimising potential
harms of the intervention. This systematic review forms the first phase of a wider project to address the need for
stand-alone guidance for public health researchers on designing and conducting exploratory studies. The review
objectives were to identify and examine existing recommendations concerning when such studies should be
undertaken, questions they should answer, suitable methods, criteria for deciding whether to progress to an
effectiveness study and appropriate reporting.
Methods: We searched for published and unpublished guidance reported between January 2000 and November
2016 via bibliographic databases, websites, citation tracking and expert recommendations. Included papers were
thematically synthesized.
Results: The search retrieved 4095 unique records. Thirty papers were included, representing 25 unique sources of
guidance/recommendations. Eight themes were identified: pre-requisites for conducting an exploratory study,
nomenclature, guidance for intervention assessment, guidance surrounding any future evaluation study design,
flexible versus fixed design, progression criteria to a future evaluation study, stakeholder involvement and reporting
of exploratory studies. Exploratory studies were described as being concerned with the intervention content, the
future evaluation design or both. However, the nomenclature and endorsed methods underpinning these aims
were inconsistent across papers. There was little guidance on what should precede or follow an exploratory study
and decision-making surrounding this.
Conclusions: Existing recommendations are inconsistent concerning the aims, designs and conduct of exploratory
studies, and guidance is lacking on the evidence needed to inform when to proceed to an effectiveness study.
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Background
Improving public health and disrupting complex prob-
lems such as smoking, obesity and mental health re-
quires complex, often multilevel, interventions. Such
interventions are often costly and may cause unantici-
pated harms and therefore require evaluation using the
most robust methods available. However, pressure to
identify effective interventions can lead to premature
commissioning of large effectiveness studies of poorly
developed interventions, wasting finite research re-
sources [1–3]. In the development of pharmaceutical
drugs over 80% fail to reach ‘Phase III’ effectiveness tri-
als, even after considerable investment [4]. With public
health interventions, the historical tendency to rush to
full evaluation has in some cases led to evaluation fail-
ures due to issues which could have been identified at
an earlier stage, such as difficulties recruiting sufficient
participants [5]. There is growing consensus that im-
proving the effectiveness of public health interventions
relies on attention to their design and feasibility [3, 6].
However, what constitutes good practice when deciding
when a full evaluation is warranted, what uncertainties
should be addressed to inform this decision and how, is
unclear. This systematic review aims to synthesize exist-
ing sources of guidance for ‘exploratory studies’ which
we broadly define as studies intended to generate evi-
dence needed to decide whether and how to proceed
with a full-scale effectiveness study. They do this by
optimising or assessing the feasibility of the intervention
and/or evaluation design that the effectiveness study
would use. Hence, our definition includes studies vari-
ously referred to throughout the literature as ‘pilot stud-
ies’, ‘feasibility studies’ or ‘exploratory trials’. Our
definition is consistent with previous work conducted by
Eldridge et al. [7, 8], who define feasibility as an over-
arching concept [8] which assesses; ‘… whether the fu-
ture trial can be done, should be done, and, if so, how’
(p. 2) [7]. However, our definition also includes explora-
tory studies to inform non-randomised evaluations, ra-
ther than a sole focus on trials.
The importance of thoroughly establishing the feasibil-
ity of intervention and evaluation plans prior to embark-
ing on an expensive, fully powered evaluation was
indicated in the Medical Research Council’s (MRC)
framework for the development and evaluation of
complex interventions to improve health [9, 10]. This
has triggered shifts in the practice of researchers and
funders toward seeking and granting funding for an ever
growing number of studies to address feasibility issues.
Such studies are however in themselves often expensive
[11, 12]. While there is a compelling case for such
studies, the extent to which this substantial investment
in exploratory studies has to date improved the effective-
ness and cost-effectiveness of evidence production
remains to be firmly established. Where exploratory
studies are conducted poorly, this investment may sim-
ply lead to expenditure of large amounts of additional
public money, and several years’ delay in getting evi-
dence into the hands of decision-makers, without neces-
sarily increasing the likelihood that a future evaluation
will provide useful evidence.
The 2000 MRC guidance used the term ‘exploratory
trial’ for work conducted prior to a ‘definitive trial’, indi-
cating that it should primarily address issues concerning
the optimisation, acceptability and delivery of the inter-
vention [13]. This included adaptation of the interven-
tion, consideration of variants of the intervention,
testing and refinement of delivery method or content,
assessment of learning curves and implementation strat-
egies and determining the counterfactual. Other possible
purposes of exploratory trials included preliminary as-
sessment of effect size in order to calculate the sample
size for the main trial and other trial design parameters,
including methods of recruitment, randomisation and
follow-up. Updated MRC guidance in 2008 moved away
from the sole focus on RCTs (randomised controlled tri-
als) of its predecessor reflecting recognition that not all
interventions can be tested using an RCT and that the
next most robust methods may sometimes be the best
available option [10, 14]. Guidance for exploratory stud-
ies prior to a full evaluation have, however, often been
framed as relevant only where the main evaluation is to
be an RCT [13, 15].
However, the goals of exploratory studies advocated by
research funders have to date varied substantially. For
instance, the National Institute for Health Research
Evaluation Trials and Studies Coordinating Centre
(NETSCC) definitions of feasibility and pilot studies do
not include examination of intervention design, delivery
or acceptability and do not suggest that modifications to
the intervention prior to full-scale evaluation will arise
from these phases. However, the NIHR (National Insti-
tute of Health Research) portfolio of funded studies indi-
cates various uses of terms such as ‘feasibility trial’, ‘pilot
trial’ and ‘exploratory trial’ to describe studies with simi-
lar aims, while it is rare for such studies not to include a
focus on intervention parameters [16–18]. Within the
research literature, there is considerable divergence over
what exploratory studies should be called, what they
should achieve, what they should entail, whether and
how they should determine progression to future studies
and how they should be reported [7, 8, 19–21].
This paper presents a systematic review of the existing
recommendations and guidance on exploratory studies
relevant to public health, conducted as the first stage of a
project to develop new MRC guidance on exploratory
studies. This review aims to produce a synthesis of current
guidance/recommendations in relation to the definition,
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purpose and content of exploratory studies, and what is
seen as ‘good’ and ‘bad’ practice as presented by the au-
thors. It will provide an overview of key gaps and areas in
which there is inconsistency within and between docu-
ments. The rationale for guidance and recommendations
are presented, as well as the theoretical perspectives
informing them. In particular, we examine how far the
existing recommendations answer the following questions:
 When is it appropriate to conduct an exploratory study?
 What questions should such studies address?
 What are the key methodological considerations in
answering these questions?
 What criteria should inform a decision on whether
to progress to an effectiveness study?
 How should exploratory studies be reported?
Methods
This review is reported in accordance with the PRISMA
(Preferred Reporting Items for Systematic Reviews and
Meta-Analyses) statement [22] as evidenced in the
PRISMA checklist (see Additional file 1: Table S1). The re-
view protocol is registered on PROSPERO (registration
number: CRD42016047843; www.crd.york.ac.uk/prospero).
Literature search
A comprehensive search (see Additional file 2:
Appendix) was designed and completed during August to
November 2016 to identify published and grey literature
reported between January 2000 and November 2016 that
contained guidance and recommendations on exploratory
studies that could have potential relevance to public
health. Bibliographic databases were CINAHL, Embase,
MEDLINE, MEDLINE-In-process, PsycINFO, Web of
Science and PubMed. Supplementary searches included
key websites (see Additional file 2: Appendix) and forward
and backward citation tracking of included papers, as well
as contacting experts in the field. The first MRC guidance
on developing and evaluating complex interventions in
health was published in 2000; we therefore excluded guid-
ance published before this year.
Selection of included papers
Search results were exported into reference management
software Endnote and clearly irrelevant or duplicate re-
cords removed by an information specialist. Eligibility cri-
teria were applied to abstracts and potentially relevant
full-text papers by two reviewers working independently
in duplicate (BH, JS). Discrepancies were agreed by con-
sensus or by a third reviewer if necessary. Full criteria are
shown in Table 1. During screening of eligible studies, it
became evident that determining whether or not guidance
was applicable to public health was not always clear. The
criteria in Table 1 were agreed by the team after a list of
potentially eligible publications were identified.
Quality assessment of included papers
Given the nature of publications included (expert guid-
ance or methodological discussion papers) quality as-
sessment was not applicable.
Data extraction and thematic synthesis
A thematic synthesis of guidance within included docu-
ments was performed [23]. This involved the use of an a
priori coding framework (based on the projects aims
and objectives), developed by RT, JS and DW ([24], see
Additional file 2: Appendix). Data were extracted using
this schema in qualitative analytic software NVivo by
one reviewer (BH). A 10% sample of coded papers was
checked by a second reviewer (JS). Data were then
conceptualised into final themes by agreement (BH, JS,
DW, RT).
Table 1 Eligibility criteria for selecting papers
Eligibility criteria
Definition of exploratory study • A study which aims to generate the evidence needed to decide whether and how to proceed with
a full-scale effectiveness trial, or other study design and are labelled as exploratory/pilot/feasibility/
phase II/proof of concept. Eligible publications may concern some or all of the design features of
exploratory studies
Nature of guidance • Guidance on the purpose, design, implementation or reporting of exploratory studies
and/or
• Other publication that reports ‘substantive information’ concerning the conduct of exploratory
studies within public health—e.g. worked examples and methodological papers
Applicability to public health • Public health audiences clearly among intended users of the guidance (authors are from Public
Health departments, cites literature from public health journals, provides public health examples
or uses the term ‘public health’ or variants of this, e.g. ‘prevention science’)
or
• Unspecific audience but of plausible relevance to public health (might, for example, include
either an author from a public health research department or a citation to a public health journal)
Publication type/source Book, book chapter, journal article, report or readily available doctoral thesis, funding organisation
websites (UK and non-UK based)
Date and language restrictions Publications reported since 2000 to date (November 2016), in any language.
Hallingberg et al. Pilot and Feasibility Studies  (2018) 4:104 Page 3 of 12
Results
Review statistics
Four thousand ninety-five unique records were identified
of which 93 were reviewed in full text (see Fig. 1). In total,
30 documents were included in the systematic review
representing 25 unique sets of guidance. Most sources of
guidance did not explicitly identify an intended audience
and guidance varied in its relevance to public health.
Table 2 presents an overview of all sources of guidance in-
cluded in the review with sources of guidance more or less
relevant to public health identified as well as those which
specifically applied to exploratory studies with a rando-
mised design.
Findings from guidance
The included guidance reported a wide range of recom-
mendations on the process of conducting and reporting
exploratory studies. We categorised these into eight
themes that capture: pre-requisites for conducting an
exploratory study, nomenclature, guidance for inter-
vention assessment, guidance surrounding the future
evaluation study design, adaptive vs rigid designs,
progression criteria for exploratory studies, stake-
holder involvement and reporting.
Narrative description of themes
Theme 1: pre-requisites for conducting an exploratory study
Where mentioned, pre-requisite activities included de-
termining the evidence base, establishing the theoretical
basis for the intervention, identifying the intervention
components as well as modelling of the intervention in
order to understand how intervention components
interact and impact on final outcomes [9, 25–27]. These
were often discussed within the context of the MRC’s
Fig. 1 Flow diagram
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Table 2 Summary of included guidance
Aims outlined and endorsed by authorsc
Intervention future evaluation
First author(s) Document
type
Greater relevance
to public healtha
Nomenclature
used
Refine Implementation Impact Design
feasibility
Parameter
estimation
Arain et al. (2010) [19] journal
publication
pilot studyb x
feasibility study x
Bowen et al. (2009) [39] journal
publication
✓ feasibility x x x x
Campbell et al. (2000) [9] journal
publication
✓ phase II stage;
exploratory trial
x x x
Cook et al. (2014) [35] report to
funder
pilot study x
Craig et al. (2008) [10] funder report ✓ feasibility/piloting
stage; pilot study
x x x
Dixon-Woods et al. (2004) [23] journal
publication
exploratory clinical
trial/phase II
Eldridge, Chan et al. (2016) [7] journal
publication
✓ pilot trialsb x x x
feasibility trials x x x
Eldridge, Lancaster et al. (2016) [8] journal
publication
✓ pilot and feasibility
studiesb
-feasibility studies
that are not pilot
studies
x x
-non-randomised
pilot studies
x
-randomised pilot
studies
x
Eldridge, Costelloe et al. (2016) [41] journal
publication
pilot study x x x x
Evans et al. (2013) [28] journal
publication
✓ feasibility and
piloting stage
Feeley et al. (2009) [30] journal
publication
pilot study x x x x
Fletcher et al. (2016) [29] journal
publication
✓ pilot studyb x x x
feasibility study x x x
Hislop et al. (2014) [43] journal
publication
pilot study x x
Lancaster (2004) [36] journal
publication
pilot studies x x x
Lancaster et al. (2015) [20] journal
publication
pilot and feasibility
studies
x x x
Levati et al. (2016) [31] journal
publication
✓ pilot and feasibility
studies
x
Moffatt et al. (2006) [42] journal
publication
(worked
example)
✓ pilot study
Möhler et al. (2012) [25] journal
publication
feasibility and
piloting stage;
pilot study
x
Möhler et al. (2013) [26] journal
publication
feasibility and
piloting stage;
pilot study
x
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intervention development-evaluation cycle [6, 9, 10, 13,
25–28]. Understanding how intervention components
interact with various contextual settings [6, 27, 29] and
identifying unintended harms [6, 29] as well as potential
implementation issues [6, 9, 10, 30] were also
highlighted. There was an absence of detail in judging
when these above conditions were met sufficiently for
moving onto an exploratory study.
Theme 2: nomenclature
A wide range of terms were used, sometimes inter-
changeably, to describe exploratory studies with the
most common being pilot trial/study. Table 3 shows the
frequency of the terms used in guidance including other
terms endorsed.
Different terminology did not appear to be consistently
associated with specific study purposes (see theme 3), as
illustrated in Table 2. ‘Pilot’ and ‘feasibility’ studies were
Table 2 Summary of included guidance (Continued)
Aims outlined and endorsed by authorsc
Intervention future evaluation
First author(s) Document
type
Greater relevance
to public healtha
Nomenclature
used
Refine Implementation Impact Design
feasibility
Parameter
estimation
Möhler et al. (2015) [27] journal
publication
feasibility and
piloting stage;
pilot study
x
Medical Research Council (2000)
[13]
funder report ✓ phase II stage;
exploratory trial
x x x x x
National Institute for Health
Research, ‘Feasibility and Pilot
studies’ (Accessed 14/10/16)
funder
document
pilot studyb x x
feasibility study x x x
National Institute for Health
Research, ‘Progression rules for
internal pilot studies for HTA trials’
(Accessed 14/10/16)
funder
document
internal pilot
studies
x
National Institute for Health
Research, ‘Glossary’ (14/10/16)
funder website pilot studyb x x
feasibility study x x
O'Cathain et al. (2015) [15] journal
publication
✓ feasibility study x x x x
Shanyinde et al. (2011) [21] journal
publication
pilot / feasibility
trials
Strong et al. (2009) [40] journal
publication
✓ pilot intervention x x
Taylor et al. (2015) [34] book chapter ✓ pilot studyb x x
feasibility study x x
Westlund et al. (2016) [38] journal
publication
pilot study x x
Wight et al. (2015) [6] journal
publication
✓ specific term not
stated
x x x x x
aGuidance with greater relevance to public health included those where public health audiences was clearly among intended users of the guidance (authors are
from Public Health departments, cites literature from public health journals, provides public health examples or uses the term ‘public health’ or variants of this,
e.g. ‘prevention science’, ‘health improvement’). Guidance with less relevance was not specific about the intended audience but was of plausible relevance to
public health (might, for example, include either an author from a public health research department or a citation to a public health journal).
bAuthors make distinctions between the terms “pilot study” and “feasibility study”. c Aims of exploratory studies presented in the table map onto aims presented
in themes 3 (Guidance for intervention assessment) and 4 (Guidance surrounding the future evaluation design)
Table 3 Frequency of nomenclature used
Nomenclature Number of sources
Pilot trial/study 16
Feasibility trial/study 8
Feasibility and piloting stage 5
Pilot and/or feasibility trial/study 5
Phase II trial/study 3
Exploratory trial/study 3
Other terms (external pilot, feasibility
studies but not pilot studies, non-
randomised pilot studies, randomised
feasibility studies, randomised pilot
studies, exploratory pilot study,
feasibility RCT, formative study,
phase II stage, pilot RCT, process
evaluation with a pilot trial,
randomised feasibility trial,
randomised pilot trial)
Terms presented once or
twice across different
sources of guidance.
Note: terms are not mutually exclusive
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sometimes used interchangeably [10, 20, 25–28, 31] while
others made distinctions between the two according to
design features or particular aims [7, 8, 19, 29, 32–34]. For
example, some described pilot studies as a smaller version
of a future RCT to run in miniature [7, 8, 19, 29, 32–34]
and was sometimes associated with a randomised design
[32, 34], but not always [7, 8]. In contrast, feasibility
studies were used as an umbrella term by Eldridge et al.
with pilot studies representing a subset of feasibility
studies [7, 8]: ‘We suggest that researchers view feasibility
as an overarching concept, with all studies done in prepar-
ation for a main study open to being called feasibility stud-
ies, and with pilot studies as a subset of feasibility studies.’
(p. 18) [8].
Feasibility studies could focus on particular interven-
tion and trial design elements [29, 32] which may not in-
clude randomisation [32, 34]. Internal pilot studies were
primarily viewed as part of the full trial [8, 32, 35–38]
and are therefore not depicted under nomenclature
in Table 3.
While no sources explicitly stated that an exploratory
study should focus on one area and not the other, aims
and associated methods of exploratory studies diverged
into two separate themes. They pertained to either
examining the intervention itself or the future evaluation
design, and are detailed below in themes 3 and 4.
Theme 3: guidance for intervention assessment
Sources of guidance endorsed exploratory studies having
formative purposes (i.e. refining the intervention and
addressing uncertainties related to intervention imple-
mentation [13, 15, 29, 31, 39]) as well as summative
goals (i.e. assessing the potential impact of an interven-
tion or its promise [6, 13, 39]).
Refining the intervention and underlying theory
Some guidance suggested that changes could be made
within exploratory studies to refine the intervention and
underlying theory [15, 29, 31] and adapt intervention
content to a new setting [39]. However, guidance was
not clear on what constituted minor vs. major changes
and implications for progression criteria (see theme 6).
When making changes to the intervention or underlying
theory, some guidance recommended this take place
during the course of the exploratory study (see theme 5).
Others highlighted the role of using a multi-arm design
to select the contents of the intervention before a full
evaluation [13] and to assess potential mechanisms of
multiple different interventions or intervention compo-
nents [29]. Several sources highlighted the role of quali-
tative research in optimising or refining an intervention,
particularly for understanding the components of the
logic model [29] and surfacing hidden aspects of the
intervention important for delivering outcomes [15].
Intervention implementation
There was agreement across a wide range of guidance
that exploratory studies could explore key uncertainties
related to intervention implementation, such as accept-
ability, feasibility or practicality. Notably these terms
were often ill-defined and used interchangeably. Accept-
ability was considered in terms of recipients’ reactions
[7, 8, 29, 32, 39] while others were also attentive to feasi-
bility from the perspective of intervention providers, de-
liverers and health professionals [6, 9, 29, 30, 34, 39].
Implementation, feasibility, fidelity and ‘practicality’ ex-
plored the likelihood of being able to deliver in practice
what was intended [25–27, 30, 39]. These were some-
times referred to as aims within an embedded process
evaluation that took place alongside an exploratory
study, although the term process evaluation was never
defined [7, 10, 15, 29, 40].
Qualitative research was encouraged for assessment of
intervention acceptability [21] or for implementation
(e.g. via non-participant observation [15]). Caution was
recommended with regards to focus groups where there is
a risk of masking divergent views [15]. Others recom-
mended quantitative surveys to examine retention rates
and reasons for dropout [7, 30]. Furthermore, several
sources emphasised the importance of testing implemen-
tation in a range of contexts [15, 29, 39, 41]—especially in
less socioeconomically advantaged groups, to examine the
risk of widening health inequalities [29, 39].
One source of guidance considered whether randomisa-
tion was required for assessing intervention acceptability,
believing this to be unnecessary but also suggesting it
could ‘potentially depend on preference among interven-
tions offered in the main trial’ ([21]; p. 9). Thus, issues of
intervention acceptability, particularly within multi-arm
trials, may relate to clinical equipoise and acceptability of
randomisation procedures among participants [30].
Appropriateness of assessing intervention impact
Several sources of guidance discussed the need to under-
stand the impact of the intervention, including harms,
benefits or unintended consequences [6, 7, 15, 29, 39].
Much of the guidance focused on statistical tests of ef-
fectiveness with disagreement on the soundness of this
aim, although qualitative methods were also recom-
mended [15, 42]. Some condemned statistically testing
for effectiveness [7, 20, 29, 32, 41], as such studies are
often underpowered, hence leading to imprecise and po-
tentially misleading estimates of effect sizes [7, 20].
Others argued that an estimate of likely effect size could
evidence the intervention was working as intended and
not having serious unintended harms [6] and thus be
used to calculate the power for the full trial [13]. Later
guidance from the MRC is more ambiguous than earlier
guidance, stating that estimates should be interpreted
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with caution, while simultaneously stating ‘safe’ assump-
tions of effect sizes as a pre-requisite before continuing
to a full evaluation [10]. NIHR guidance, which distin-
guished between pilot and feasibility studies, supported
the assessment of a primary outcome in pilot studies, al-
though it is unclear whether this is suggesting that a
pilot should involve an initial test of changes in the pri-
mary outcome, or simply that the primary outcome
should be measured in the same way as it would be in a
full evaluation. By contrast, for ‘feasibility studies’, it indi-
cated that an aim may include designing an outcome
measure to be used in a full evaluation.
Others made the case for identifying evidence of
potential effectiveness, including use of interim or surro-
gate endpoints [7, 41], defined as ‘…variables on the
causal pathway of what might eventually be the primary
outcome in the future definitive RCT, or outcomes at
early time points, in order to assess the potential for the
intervention to affect likely outcomes in the future de-
finitive RCT…’ [7] (p. 14).
Randomisation was implied as a design feature of ex-
ploratory studies when estimating an effect size estimate
of the intervention as it maximised the likelihood that ob-
served differences are due to intervention [9, 39], with
guidance mostly written from a starting assumption that
full evaluation will take the form of an RCT and guidance
focused less on exploratory studies for quasi-experimental
or other designs. For studies that aim to assess potential
effectiveness using a surrogate or interim outcome, using
a standard sample size calculation was recommended to
ensure adequate power, although it was noted that this
aim is rare in exploratory studies [7].
Theme 4: guidance surrounding the future evaluation
design
Sources consistently advocated assessing the feasibility
of study procedures or estimating parameters of the fu-
ture evaluation. Recommendations are detailed below.
Assessing feasibility of the future evaluation design
Assessing feasibility of future evaluation procedures was
commonly recommended [6, 7, 10, 15, 30, 32–34, 37,
41] to avert problems that could undermine the conduct
or acceptability of future evaluation [6, 15, 30]. A wide
range of procedures were suggested as requiring assess-
ments of feasibility including data collection [20, 30, 34,
36, 41], participant retention strategies [13], randomisa-
tion [7, 13, 20, 30, 34, 36, 38, 41], recruitment methods
[13, 30, 32, 34, 35, 38, 41], running the full trial protocol
[20, 30, 36], the willingness of participants to be rando-
mised [30, 32] and issues of contamination [30]. There
was disagreement concerning the appropriateness of
assessing blinding in exploratory studies [7, 30, 34], with
one source noting double blinding is difficult when
participants are assisted in changing their behaviour; al-
though assessing single blinding may be possible [30].
Qualitative [15, 30, 34], quantitative [34] and mixed
methods [7] were endorsed for assessing these processes.
Reflecting the tendency for guidance of exploratory stud-
ies to be limited to studies in preparation for RCTs, dis-
cussion of the role of randomisation at the exploratory
study stage featured heavily in guidance. Randomisation
within an exploratory study was considered necessary
for examining feasibility of recruitment, consent to ran-
domisation, retention, contamination or maintenance of
blinding in the control and intervention groups, ran-
domisation procedures and whether all the components
of a protocol can work together, although randomisation
was not deemed necessary to assess outcome burden
and participant eligibility [21, 30, 34]. While there was
consensus about what issues could be assessed through
randomisation, sources disagreed on whether random-
isation should always precede a future evaluation study,
even if that future study is to be an RCT. Contention
seemed to be linked to variation in nomenclature and
associated aims. For example, some defined pilot study
as a study run in miniature to test how all its compo-
nents work together, thereby dictating a randomised de-
sign [32, 34]. Yet for feasibility studies, randomisation
was only necessary if it reduced the uncertainties in esti-
mating parameters for the future evaluation [32, 34].
Similarly, other guidance highlighted an exploratory
study (irrespective of nomenclature) should address the
main uncertainties, and thus may not depend on ran-
domisation [8, 15].
Estimating parameters of the future evaluation design
A number of sources recommended exploratory studies
should inform the parameters of the future evaluation
design. Areas for investigation included estimating sam-
ple sizes required for the future evaluation (e.g. measur-
ing outcomes [32, 35]; power calculations [13]; derive
effect size estimates [6, 7, 39]; estimating target differ-
ences [35, 43]; deciding what outcomes to measure and
how [9, 20, 30, 36]; assessing quality of measures (e.g.
for reliability/ validity/ feasibility/ sensitivity [7, 20, 30];
identification of control group [9, 13]; recruitment, con-
sent and retention rates [10, 13, 20, 30, 32, 34, 36];
and information on the cost of the future evaluation
design [9, 30, 36].
While qualitative methods were deemed useful for
selecting outcomes and their suitable measures [15],
most guidance concentrated on quantitative methods for
estimating future evaluation sample sizes. This was con-
tentious due to the potential to over- or under-
estimate sample sizes required in a future evaluation
due to the lack of precision of estimates from a small
pilot [20, 30, 41]. Estimating sample sizes from effect
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size estimates in an exploratory study was nevertheless ar-
gued by some to be useful if there was scant literature and
the exploratory study used the same design and outcome
as the future evaluation [30, 39]. Cluster RCTs, which are
common in public health interventions, were specifically
earmarked as unsuitable for estimating parameters for
sample size calculations (e.g. intra-cluster correlation coef-
ficients) as well as recruitment and follow-up rates with-
out additional information from other resources, because
a large number of clusters and individual participants
would be required [41]. Others referred to ‘rules of thumb’
when determining sample sizes in an exploratory study
with numbers varying between 10 and 75 participants per
trial arm in individually randomised studies [7, 30, 36].
Several also recommended the need to consider a desired
meaningful difference in the health outcomes from a
future evaluation and the appropriate sample size
needed to detect this, rather than conducting sample
size calculations using estimates of likely effect size
from pilot data [30, 35, 38, 43].
A randomised design was deemed unnecessary for es-
timating costs or selecting outcomes, although was val-
ued for estimating recruitment and retention rates for
intervention and control groups [21, 34]. Where guid-
ance indicated the estimation of an effect size appropri-
ate to inform the sample size for a future evaluation, a
randomised design was deemed necessary [9, 39].
Theme 5: flexible vs. fixed design
Sources stated that exploratory studies could employ a
rigid or flexible design. With the latter, the design can
change during the course of the study, which is useful
for making changes to the intervention, as well as the fu-
ture evaluation design [6, 13, 15, 31]. Here, qualitative
data can be analysed as it is collected, shaping the ex-
ploratory study process, for instance sampling of subse-
quent data collection points [15], and clarifying
implications for intervention effectiveness [31].
In contrast, fixed exploratory studies were encouraged
when primarily investigating the future evaluation param-
eters and processes [13]. It may be that the nomenclature
used in some guidance (e.g. pilot studies that are described
as miniature versions of the evaluation) is suggesting a
distinction between more flexible vs. more stringent de-
signs. In some guidance, it was not mentioned whether
changes should be made during the course of an explora-
tory study or afterwards, in order to get the best possible
design for the future evaluation [6, 7, 21].
Theme 6: progression criteria to a future evaluation study
Little guidance was provided on what should be consid-
ered when formulating progression criteria for continu-
ing onto a future evaluation study. Some focussed on
the relevant uncertainties of feasibility [32, 39], while
others highlight specific items concerning cost-
effectiveness [10], refining causal hypotheses to be tested
in a future evaluation [29] and meeting recruitment tar-
gets [20, 34]. As discussed in themes 3 and 4, statistically
testing for effectiveness and using effect sizes for power
calculations was cautioned by some, and so criteria
based on effect sizes were not specified [38].
Greater discussion was devoted to how to weight evi-
dence from an exploratory study that addressed multiple
aims and used different methods. Some explicitly stated
progression criteria should not be judged as strict
thresholds but as guidelines using, for example, a traffic
lights system with varying levels of acceptability [7, 41].
Others highlighted a realist approach, moving away
from binary indicators to focusing on ‘what is feasible
and acceptable for whom and under what circum-
stances’ [29]. In light of the difficulties surrounding
interpretation of effect estimates, several sources rec-
ommended qualitative findings from exploratory stud-
ies should be more influential than quantitative
findings [15, 38].
Interestingly, there was ambiguity regarding progres-
sion when exploratory findings indicated substantial
changes to the intervention or evaluation design.
Sources considering this issue suggested that if ‘exten-
sive changes’ or ‘major modifications’ are made to either
(note they did not specify what qualified as such), re-
searchers should return to the exploratory [21, 30] or
intervention development phases [15].
‘Alternatively, at the feasibility phase, researchers may
identify fundamental problems with the intervention or
trial conduct and return to the development phase ra-
ther than proceed to a full trial.’ (p. 1) [15].
As described previously, however, the threshold at
which changes are determined to be ‘major’ remained
ambiguous. While updated MRC guidance [10] moved
to a more iterative model, accepting that movement
back between feasibility/piloting and intervention devel-
opment may sometimes be needed, there was no guid-
ance on under what conditions movement between
these two stages should take place.
Theme 7: stakeholder involvement
Several sources recommended a range of stakeholders
(e.g. intervention providers, intervention recipients, pub-
lic representatives as well as practitioners who might use
the evidence produced by the full trial) be involved in
the planning and running of the exploratory study to
ensure exploratory studies reflect the realities of inter-
vention setting [15, 28, 31, 32, 39, 40]. In particular,
community-based participatory approaches were recom-
mended [15, 39]. While many highlighted the value of
stakeholders on Trial Steering Committees and other
similar study groups [15, 28, 40], some warned about
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equipoise between researchers and stakeholders [15, 40]
and also cautioned against researchers conflating
stakeholder involvement with qualitative research [15].
‘Although patient and public representatives on research
teams can provide helpful feedback on the intervention,
this does not constitute qualitative research and may not
result in sufficiently robust data to inform the appropriate
development of the intervention.’ (p. 8) [15].
Theme 8: reporting of exploratory studies
Detailed recommendations for reporting exploratory
studies were recently provided in new Consolidated
Standards of Reporting Trials (CONSORT) guidance by
Eldridge et al. [7]. In addition to this, recurrent points
were brought up by other sources of guidance. Most
notably, it was recommended exploratory studies be
published in peer-reviewed journals as this can provide
useful information to other researchers on what has
been done, what did not work and what might be most
appropriate [15, 30]. An exploratory study may also re-
sult in multiple publications, but should provide refer-
ence to other work carried out in the same exploratory
study [7, 15]. Several sources of guidance also highlight
that exploratory studies should be appropriately labelled
in the title/abstract to enable easy identification; how-
ever, the nomenclature suggested varied depending on
guidance [7, 8, 15].
Discussion
While exploratory studies—carried out to inform
decisions about whether and how to proceed with an ef-
fectiveness study [7, 8]—are increasingly recognised as im-
portant in the efficient evaluation of complex public
health interventions, our findings suggest that this area re-
mains in need of consistent standards to inform practice.
At present, there are multiple definitions of exploratory
studies, a lack of consensus on a number of key issues,
and a paucity of detailed guidance on how to approach
the main uncertainties such studies aim to address prior
to proceeding to a full evaluation.
Existing guidance commonly focuses almost exclu-
sively on testing methodological parameters [33], such
as recruitment and retention, although in practice, it is
unusual for such studies not to also focus on the feasi-
bility of the intervention itself. Where intervention feasi-
bility is discussed, there is limited guidance on when an
intervention is ‘ready’ for an exploratory study and a lack
of demarcation between intervention development and
pre-evaluation work to understand feasibility. Some
guidance recognised that an intervention continues to
develop throughout an exploratory study, with distinc-
tions made between ‘optimisation/refinement’ (i.e. minor
refinements to the intervention) vs. ‘major changes’.
However, the point at which changes become so
substantial that movement back toward intervention de-
velopment rather than forward to a full evaluation re-
mains ambiguous. Consistent with past reviews which
adopted a narrower focus on studies with randomised
designs [21] or in preparation for a randomised trial [8,
36] and limited searches of guidance in medical journals
[19, 36], terms to describe exploratory studies were in-
consistent, with a distinction sometimes made between
pilot and feasibility studies, though with others using
these terms interchangeably.
The review identifies a number of key areas of dis-
agreement or limited guidance in regards to the critical
aims of exploratory studies and addressing uncertainties
which might undermine a future evaluation, and how
these aims should be achieved. There was much dis-
agreement for example on whether exploratory studies
should include a preliminary assessment of intervention
effects to inform decisions on progression to a full
evaluation, and the appropriateness of using estimates of
effect from underpowered data (from non-representative
samples and a study based on a not fully optimised ver-
sion of the intervention) to power a future evaluation
study. Most guidance focused purely on studies in prep-
aration for RCTs; nevertheless, guidance varied on
whether randomisation was a necessary feature of the
exploratory study, even where a future evaluation study
was an RCT. Guidance was often difficult to assess re-
garding its applicability to public health research, with
many sources focusing on literature and practice primar-
ily from clinical research, and limited consideration of
the transferability of these problems and proposed solu-
tions to complex social interventions, such as those in
public health. Progression criteria were highlighted as
important by some as a means of preventing biased post
hoc cases for continuation. However, there was a lack of
guidance on how to devise progression criteria and pro-
cesses for assessing whether these had been sufficiently
met. Where they had not been met, there was a lack of
guidance on how to decide whether the exploratory
study had generated sufficient insight about uncertain-
ties that the expense of a further feasibility study would
not be justified prior to large-scale evaluation.
Although our review included a broad focus on guid-
ance of exploratory studies from published and grey lit-
erature and moved beyond a focus on studies conducted
in preparation for an RCT specifically, a number of limi-
tations should be noted. Guidance from other areas of
social intervention research where challenges may be
similar to those in public health (e.g. education, social
work and business) may not have been captured by our
search strategy. We found few worked examples of ex-
ploratory studies in public health that provided substan-
tial information from learned experience and practice.
Hence, the review drew largely on recommendations
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from funding organisations, or relatively abstract guid-
ance from teams of researchers, with fewer clear exam-
ples of how these recommendations are grounded in
experience from the conduct of such studies. As such, it
should be acknowledged that these documents represent
one element within a complex system of research pro-
duction and may not necessarily fully reflect what is tak-
ing place in the conduct of exploratory studies. Finally,
treating sources of guidance as independent from each
other does not reflect how some recommendations
developed over time (see for example [7, 8, 20, 36, 41]).
Conclusion
There is inconsistent guidance, and for some key issues
a lack of guidance, for exploratory studies of complex
public health interventions. As this lack of guidance for
researchers in public health continues, the implications
and consequences could be far reaching. It is unclear
how researchers use existing guidance to shape decision-
making in the conduct of exploratory studies, and in
doing so, how they adjudicate between various conflict-
ing perspectives. This systematic review has aimed
largely to identify areas of agreement and disagreement
as a starting point in bringing order to this somewhat
chaotic field of work. Following this systematic review,
our next step is to conduct an audit of published public
health exploratory studies in peer-reviewed journals, to
assess current practice and how this reflects the
reviewed guidance. As part of a wider study, funded by
the MRC/NIHR Methodology Research Programme to
develop GUidance for Exploratory STudies of complex
public health interventions (GUEST; Moore L, et al.
Exploratory studies to inform full scale evaluations of
complex public health interventions: the need for guid-
ance, submitted), the review has informed a Delphi sur-
vey of researchers, funders and publishers of public
health research. In turn, this will contribute to a consen-
sus meeting which aims to reach greater unanimity on
the aims of exploratory studies, and how these can most
efficiently address uncertainties which may undermine a
full-scale evaluation.
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